Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Nantucket › NPI 1447214622
Hospital

Nantucket Cottage Hospital

Nantucket Cottage Hospital was paid $7.11M by Medicaid between Jan 2018 and Dec 2024, across 175 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.

33Billing provider infoNANTUCKET COTTAGE HOSPITAL
NANTUCKET, MA 02554
33aNPI1447214622assigned 04/14/2006
33bProvider typeCritical Access Hospital
28Total paid$7.11M
24GClaims183,556
24DCodes billed175
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Massachusetts

Rank by total paid#3 of 5
Median peer was paid$7.11M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201818,575$733K
201919,741$842K
202018,994$659K
202141,711$1.45M
202240,364$1.73M
202328,460$821K
2024incomplete15,711$874K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 21% 10,913 9,699 $1.52M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 7,622 6,915 $848K
96361 Intravenous infusion, hydration; each additional hour 9.8% 1,383 1,219 $700K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.2% 2,496 2,293 $511K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6.5% 8,905 3,282 $463K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 5.1% 2,959 1,016 $360K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 5.0% 3,136 2,833 $356K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.6% 4,569 3,787 $330K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.0% 821 674 $214K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2.1% 4,335 4,139 $147K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.4% 4,585 1,886 $101K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.3% 1,214 1,112 $94K
163 more codes
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.2% 1,227 $88K
99214 Doctor's office visit, returning patient (more involved) 1.2% 1,642 $85K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,346 $69K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,882 $54K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 1,801 $53K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 616 $49K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 10,100 $48K
96375 Therapeutic injection; each additional sequential IV push <1% 1,497 $44K
71046 Radiologic examination, chest; 2 views <1% 1,871 $43K
0002A <1% 1,261 $40K
77063 Screening digital breast tomosynthesis, bilateral <1% 566 $39K
0001A <1% 1,300 $38K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 289 $38K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,518 $35K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,518 $35K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 118 $32K
97161 <1% 429 $28K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 699 $27K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,602 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,820 $23K
80053 Comprehensive metabolic panel <1% 6,656 $23K
ATP14 <1% 2,658 $21K
84443 Thyroid stimulating hormone (TSH) <1% 2,380 $20K
76801 <1% 124 $20K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 568 $19K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 118 $18K
ATP15 <1% 1,945 $18K
ATP08 <1% 2,451 $17K
70450 Computed tomography, head or brain; without contrast material <1% 99 $16K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,674 $16K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 320 $14K
84484 <1% 1,472 $14K
90686 <1% 1,834 $13K
97803 <1% 172 $13K
85027 <1% 3,348 $13K
81001 <1% 5,684 $12K
80048 Basic metabolic panel (calcium, ionized) <1% 6,448 $11K
77067 Screening mammography, bilateral, including computer-aided detection <1% 570 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,111 $10K
83036 Hemoglobin; glycosylated (A1C) <1% 2,435 $10K
97162 <1% 129 $9K
87070 <1% 1,555 $9K
81025 <1% 1,836 $9K
87806 <1% 499 $9K
86803 <1% 997 $8K
83735 <1% 2,071 $8K
ATP17 <1% 943 $8K
86618 <1% 715 $8K
80050 General health panel <1% 607 $8K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 332 $7K
G0378 Hospital observation service, per hour <1% 48 $7K
83655 <1% 701 $7K
0004A <1% 177 $7K
83690 <1% 1,382 $6K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 348 $6K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 106 $6K
71045 Radiologic examination, chest; single view <1% 525 $6K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 39 $6K
99204 Doctor's office visit, new patient (more involved) <1% 64 $6K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 372 $6K
0012A <1% 167 $5K
87276 <1% 490 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 103 $4K
0011A <1% 178 $4K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 85 $4K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 146 $4K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 674 $4K
81003 <1% 2,016 $4K
85610 <1% 1,623 $3K
J3490 Unclassified drugs <1% 483 $3K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 83 $3K
87077 <1% 522 $3K
ATP03 <1% 594 $3K
76830 Ultrasound, transvaginal <1% 38 $3K
97802 <1% 38 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,726 $3K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 14 $3K
80306 <1% 247 $3K
82728 <1% 327 $2K
83605 <1% 276 $2K
86850 <1% 288 $2K
0124A <1% 44 $2K
0071A <1% 52 $2K
84702 <1% 164 $2K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 12 $2K
80061 Lipid panel <1% 3,969 $2K
J2704 Injection, propofol, 10 mg <1% 734 $2K
0064A <1% 45 $2K
84439 <1% 271 $2K
0072A <1% 35 $2K
87186 <1% 253 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 77 $1K
83550 <1% 292 $1K
85651 <1% 525 $1K
84153 <1% 102 $1K
87210 <1% 290 $1K
J7050 Infusion, normal saline solution, 250 cc <1% 691 $1K
90670 <1% 25 $1K
86140 <1% 276 $989.31
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,007 $938.30
82570 <1% 339 $899.81
87340 <1% 110 $891.56
83540 <1% 284 $863.90
86900 <1% 346 $861.38
73564 <1% 56 $849.39
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 34 $830.18
86901 <1% 330 $810.86
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,298 $726.42
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 14 $705.74
73630 <1% 27 $694.05
85018 <1% 350 $683.15
0054A <1% 24 $642.18
87040 <1% 47 $623.34
90472 Immunization administration, each additional vaccine (list separately) <1% 757 $546.48
82607 <1% 64 $502.45
85014 <1% 253 $488.59
86756 <1% 40 $470.40
73130 <1% 16 $408.34
ATP16 <1% 39 $405.18
86617 <1% 43 $384.03
87205 <1% 132 $343.07
73030 <1% 14 $317.28
73610 <1% 14 $306.26
90682 <1% 18 $280.18
J7030 Infusion, normal saline solution , 1000 cc <1% 374 $242.28
84403 <1% 13 $227.60
86592 <1% 71 $225.19
85379 <1% 27 $202.60
86780 <1% 15 $181.05
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 39 $178.17
86762 <1% 13 $170.69
86787 <1% 13 $152.75
80076 <1% 2,685 $145.88
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 142 $124.72
J7120 Ringers lactate infusion, up to 1000 cc <1% 43 $121.14
83615 <1% 319 $105.30
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 308 $101.11
87081 <1% 12 $70.20
87184 <1% 12 $62.90
82043 <1% 12 $42.24
82947 <1% 14 $38.17
85007 <1% 15 $28.17
84100 <1% 157 $21.46
84550 <1% 13 $4.12
36415 Collection of venous blood by venipuncture <1% 2,377 $3.23
J2060 Injection, lorazepam, 2 mg <1% 18 $0.92
91300 <1% 2,586 $0.02
36416 0% 554 $0.00
82962 0% 440 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 659 $0.00
J3010 Injection, fentanyl citrate, 0.1 mg 0% 41 $0.00
91301 0% 280 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 0% 15 $0.00
87468 0% 28 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 18 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 0% 710 $0.00
91312 0% 44 $0.00
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 187 $0.00
90633 0% 31 $0.00
J2270 Injection, morphine sulfate, up to 10 mg 0% 15 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 45 $0.00
87469 0% 14 $0.00
90734 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFISHMAN, AARON (VP FINANCE)